High Tide (NASDAQ:HITI) vs. Glucose Health (OTCMKTS:GLUC) Critical Review

High Tide (NASDAQ:HITI) and Glucose Health (OTCMKTS:GLUC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Valuation and Earnings

This table compares High Tide and Glucose Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
High Tide	$381.22 million	0.59	-$3.19 million	($0.08)	-31.88
Glucose Health	$380,000.00	24.51	-$320,000.00	($0.03)	-15.19

Glucose Health has lower revenue, but higher earnings than High Tide. High Tide is trading at a lower price-to-earnings ratio than Glucose Health, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

High Tide has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Glucose Health has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.

Institutional and Insider Ownership

4.5% of High Tide shares are held by institutional investors. 12.4% of High Tide shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares High Tide and Glucose Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
High Tide	-1.66%	-6.50%	-3.84%
Glucose Health	-108.70%	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for High Tide and Glucose Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
High Tide	1	0	2	1	2.75
Glucose Health	0	0	0	0	0.00

High Tide presently has a consensus target price of $6.13, suggesting a potential upside of 140.20%. Given High Tide’s stronger consensus rating and higher possible upside, research analysts plainly believe High Tide is more favorable than Glucose Health.

Summary

High Tide beats Glucose Health on 8 of the 15 factors compared between the two stocks.

About High Tide

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. It operates licensed retail cannabis stores; and provides data analytics services. In addition, the company manufactures and distributes consumption accessories. Further, it sells its products through online sales via e-commerce platform. The company offers its products under the Daily High Club, DankStop, FABCBD, GC, Nuleaf, Smoke Cartel, and Blessed CBD brands. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.

About Glucose Health

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.